BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 12041977)

  • 1. Observations on a consecutive series of patients who have had Trilucent breast implants removed as recommended by the MDA Hazard Notice (May 2000).
    McGregor JC; Brown DT
    Br J Plast Surg; 2002 Apr; 55(3):231-4. PubMed ID: 12041977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histological examination of the capsules surrounding Trilucent breast implants.
    McArthur PA; Green AR; Hancock K; Green AR
    Br J Plast Surg; 2001 Dec; 54(8):684-6. PubMed ID: 11728111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trilucent breast implants: a 3 year series.
    Rizkalla M; Duncan C; Matthews RN
    Br J Plast Surg; 2001 Mar; 54(2):125-7. PubMed ID: 11207121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience of explantation of Trilucent breast implants.
    Rizkalla M; Webb J; Chuo CB; Matthews RN
    Br J Plast Surg; 2002 Mar; 55(2):117-9. PubMed ID: 11987943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Histological and immunohistochemical investigations with capsular contracture after breast augmentation with smooth silicone gel implants].
    Prantl L; Schreml S; Fichtner-Feigl S; Pöppl N; Roll C; Eisenmann-Klein M; Hofstädter F
    Handchir Mikrochir Plast Chir; 2006 Aug; 38(4):224-32. PubMed ID: 16991042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trilucent breast implants: five years' experience from an Italian perspective.
    Cicchetti S; Spina B; Nicolò G; Santi PL
    Ann Plast Surg; 2003 Sep; 51(3):229-35. PubMed ID: 12966232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance imaging of Trilucent TM breast implants.
    Elson EM; Jones A; King R; Chapman P; Stanek J; Irvine AT; Bingham JB
    Clin Radiol; 2002 Apr; 57(4):263-7. PubMed ID: 12014870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter study to assess potential hazards from exposure to lipid peroxidation products in soya bean oil from Trilucent breast implants.
    Williams GM; Caldwell J; Armstrong D; Bartsch H; Bevan R; Browne RW; Chipman JK; Iatropoulos MJ; Jeffrey AM; Lunec J; Nair J; Page DL; Reeves BC; Richardson A; Silverstein B; Williams DF
    Regul Toxicol Pharmacol; 2009 Mar; 53(2):107-20. PubMed ID: 19027814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective study on Trilucent soybean oil-filled breast prosthesis.
    Scuderi N; Mazzocchi M; Alfano C; Onesti MG
    Plast Reconstr Surg; 2005 Sep; 116(4):1130-6. PubMed ID: 16163107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-stage augmentation combined with mastopexy: aesthetic results and patient satisfaction.
    Spear SL; Pelletiere CV; Menon N
    Aesthetic Plast Surg; 2004; 28(5):259-67. PubMed ID: 15529204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective study of clinical findings and changes in 56 Trilucent implant explantations.
    Münker R; Zörner C; McKiernan D; Opitz J
    Aesthetic Plast Surg; 2001; 25(6):421-6. PubMed ID: 11731847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of local complications following explantation of silicone breast implants.
    Siggelkow W; Klosterhalfen B; Klinge U; Rath W; Faridi A
    Breast; 2004 Apr; 13(2):122-8. PubMed ID: 15019692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient retention and replacement trends after saline breast implants: are deflations inflationary?
    Stevens WG; Pacella SJ; Hirsch E; Stoker DA
    Aesthetic Plast Surg; 2009 Jan; 33(1):54-7. PubMed ID: 18752020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of radiotherapy on capsule formation and aesthetic outcome after immediate breast reconstruction using biodimensional anatomical expander implants.
    Behranwala KA; Dua RS; Ross GM; Ward A; A'hern R; Gui GP
    J Plast Reconstr Aesthet Surg; 2006; 59(10):1043-51. PubMed ID: 16996426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trilucent breast implants--a personal review of the current controversies (May 1999).
    McGregor JC
    Scott Med J; 2000 Dec; 45(6):177-9. PubMed ID: 11216309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do biomaterials cause implant-associated mesenchymal tumors of the breast? Analysis of 8 new cases and review of the literature.
    Balzer BL; Weiss SW
    Hum Pathol; 2009 Nov; 40(11):1564-70. PubMed ID: 19540553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mastectomy with breast reconstruction in previously augmented patients: indications for implant removal.
    Robbins CM; Long JN; Fix RJ; de la Torre JI; Vasconez LO
    Ann Plast Surg; 2008 Nov; 61(5):500-5. PubMed ID: 18948775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective, multi-center study of psychosocial outcomes after augmentation with natrelle silicone-filled breast implants.
    Murphy DK; Beckstrand M; Sarwer DB
    Ann Plast Surg; 2009 Feb; 62(2):118-21. PubMed ID: 19158517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trilucent breast implants: voluntary removal following the Medical Device Agency recommendation. Report on 115 consecutive patients.
    Gherardini G; Zaccheddu R; Basoccu G
    Plast Reconstr Surg; 2004 Mar; 113(3):1024-7. PubMed ID: 15108901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnosis of breast implant rupture: MRI findings compared with findings at explantation.
    Hölmich LR; Vejborg I; Conrad C; Sletting S; McLaughlin JK
    Eur J Radiol; 2005 Feb; 53(2):213-25. PubMed ID: 15664285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.